Melius Pharma is a pharmaceutical company that focuses on the development of new treatments for interstitial lung diseases.
Melius Pharma has raised $1.8M in total funding. The most recent round was Series A. The last funding was announced in May 2022.
Melius Pharma's investors include Fåhraeus Startup and Growth.
Melius Pharma is headquartered in Stocksund, Sweden.
Melius Pharma is a pharmaceutical company that focuses on the development of new treatments for interstitial lung diseases.
Melius Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Melius Pharma — Funding & Investors." VCBacked, May 3, 2022, https://www.vcbacked.co/company/melius-pharma. Accessed September 30, 2026.
VCBacked. (2022). Melius Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/melius-pharma
{{cite web |title=Melius Pharma — Funding & Investors |url=https://www.vcbacked.co/company/melius-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated